← Leaderboards
Charles Natanson
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
- Mark Thomas Gladwin$38,765,597
- Peter Eichacker$0
- Alan Remaley$0
- Glen Hortin$0
- Roberto F Machado$0
Others in their field
Top investigators on “Septic Shock”
- Jonathan Michael Dean · University Of Utah$14,273,626
- Ping Wang · Feinstein Institute For Medical Research$13,465,791
- Judy Lieberman · Boston Children'S Hospital$11,932,630
- Hector R. Wong · Children'S Hospital Med Ctr (Cincinnati)$11,418,295
- William R Green · Dartmouth College$11,404,802
- Alfred Ayala · Rhode Island Hospital (Providence, Ri)$11,036,838
Research focus
Septic ShockCanis FamiliarisDogsNonhuman Therapy EvaluationProtocols DocumentationDisease /Disorder ModelOrganCessation Of LifeAnimalsCellsTumor Necrosis Factor AlphaCytokineAcuteSepsisAdverse EffectsNitric OxideHemodynamicsBlood PressurePhosphorylationEnzyme InhibitorsPhysiologicalPhysiologyLipopolysaccharidesMicroorganism Disease Chemotherapy
Grant awards (37)
The Effect of glucocorticoids and mineralocorticoids in a Sedated and Ventilated Model of Canine Sepsis$0
ZIA · FY2016 · CL · contact PI
The Effect of glucocorticoids and mineralocorticoids in a Sedated and Ventilated Model of Canine Sepsis$0
ZIA · FY2015 · CL · contact PI
The Effect of glucocorticoids and mineralocorticoids in a Sedated and Ventilated Model of Canine Sepsis$0
ZIA · FY2014 · CL · contact PI
The Effect of Angeli's salt on Acute Hemolysis in a Canine Model$0
ZIA · FY2014 · CL · contact PI
The Effect of Angeli's salt on Acute Hemolysis in a Canine Model$0
ZIA · FY2012 · CL · contact PI
The Effect of Glucocorticoids in a Sedated and Ventilated Model of Canine Sepsis$0
ZIA · FY2012 · CL · contact PI
The Effect of Angeli's salt on Acute Hemolysis in a Canine Model$0
ZIA · FY2010 · CL · contact PI
The Effect of Glucocorticoids in a Sedated and Ventilated Model of Canine Sepsis$0
ZIA · FY2010 · CL · contact PI
The Effect of Angeli's salt on Acute Hemolysis in a Canine Model$0
ZIA · FY2009 · CL · contact PI
The Effect of Glucocorticoids in a Sedated and Ventilated Model of Canine Sepsis$0
ZIA · FY2009 · CL · contact PI
The Effect of Glucocorticoids in a Sedated and Ventilated Model of Canine Sepsis$264,521
Z01 · FY2008 · CL · contact PI
Development of a Mechanically Ventilated and Sedated Model of Canine Septic Shoc$151,155
Z01 · FY2008 · CL · contact PI
The Effect of Angeli's salt on Acute Hemolysis in a Canine Model$113,366
Z01 · FY2008 · CL · contact PI
The Effect of Sodium Nitrite on Acute Hemolysis in a Canine Model$113,366
Z01 · FY2008 · CL · contact PI
The Effect of Glucocorticoids in a Sedated and Ventilated Model of Canine Sepsis$279,765
Z01 · FY2007 · CL · contact PI
Development of a Mechanically Ventilated and Sedated Model of Canine Septic Shoc$159,866
Z01 · FY2007 · CL · contact PI
The Effect of Angeli¿s salt on Acute Hemolysis in a Canine Model$119,899
Z01 · FY2007 · CL · contact PI
The Effect of Sodium Nitrite on Acute Hemolysis in a Canine Model$119,899
Z01 · FY2007 · CL · contact PI
Tyrphostin Ag 556 Therapy Adjusted To Severity Of Illnes$0
Z01 · FY2005 · CL
Investigations Of New Therapies In Septic Shock$0
Z01 · FY2005 · CL
Tyrphostin Ag 556 Therapy Adjusted To Severity Of Illnes$0
Z01 · FY2004 · CL
Investigations Of New Therapies In Septic Shock$0
Z01 · FY2004 · CL
Investigations Of New Therapies In Septic Shock$0
Z01 · FY2003 · CL
Tyrphostin Ag 556 Therapy Adjusted To Severity Of Illnes$0
Z01 · FY2003 · CL
Effect Of Nitric Oxide Synthase Inhibitors In Vivo Tumor$0
Z01 · FY2002 · CL
Tyrphostin Ag 556 Therapy Adjusted To Severity Of Illnes$0
Z01 · FY2002 · CL
A Controlled Trial Of Tyrosine Kinase Inhibitors In A Ca$0
Z01 · FY2002 · CL
Investigations Of New Therapies In Septic Shock$0
Z01 · FY2002 · CL
Nitric Oxide In Myocardial Depression$0
Z01 · FY2001 · CL
Tyrphostin Ag 556 Therapy Adjusted To Severity Of Illnes$0
Z01 · FY2001 · CL
A Controlled Trial Of Tyrosine Kinase Inhibitors In A Ca$0
Z01 · FY2001 · CL
Effect Of Reconstituted High-density Lipoproteins In A C$0
Z01 · FY2001 · CL
Investigations Of New Therapies In Septic Shock$0
Z01 · FY2001 · CL
Effect of Nitric Oxide Synthase Inhibitors in Vivo Tumor Necrosis Factor-induced$0
Z01 · FY2000 · CL
Tyrphostin AG 556 Therapy Adjusted to Severity of Illness of New Therapies in Se$0
Z01 · FY2000 · CL
A Controlled Trial of Tyrosine Kinase Inhibitors in a Canine Model of Septic Sho$0
Z01 · FY2000 · CL
Investigations of New Therapies in Septic Shock$0
Z01 · FY2000 · CL